Equivir G
Broad-Spectrum Antiviral (Prescription Drug)
Preclinical/DiscoveryActive
Key Facts
Indication
Broad-Spectrum Antiviral (Prescription Drug)
Phase
Preclinical/Discovery
Status
Active
Company
About ProPhase Labs
ProPhase Labs is a publicly-traded, multi-faceted healthcare company with a mission to create a healthier world through bold action and data-driven insight. The company has successfully pivoted from its consumer health origins, generating significant revenue through its diagnostic labs and Nebula Genomics subsidiary, while strategically investing in longer-term, high-potential biopharma programs. Its strategy hinges on executional excellence, smart diversification, and leveraging synergies between its business segments—genomics, biopharma, and consumer products—to drive toward its stated ambition of becoming a multibillion-dollar enterprise.
View full company profile